Tricuspid atresia

•Download as PPT, PDF•

21 likes•12,228 views

Some babies with tricuspid atresia have other conditions, such as pulmonary stenosis or transposition of the great arteries, that also affect blood flow through their heart. These conditions require treatment, too.

Health & Medicine

Tricuspid atresia http://en.wikipedia.org/wiki/Tricuspid_atresia

Clinical manifestations ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Treatment ,[object Object],[object Object],[object Object],[object Object]

A cyanotic heart defect is a group-type of congenital heart defects (CHDs). The patient appears blue (cyanotic), due to deoxygenated blood bypassing the lungs and entering the systemic circulation. This can be caused by right-to-left or bidirectional shunting, or malposition of the great arteries. Cyanotic heart defects, which account for approximately 25% of all CHDs, include: Tetralogy of Fallot (ToF) Total anomalous pulmonary venous connection Hypoplastic left heart syndrome (HLHS) Transposition of the great arteries (d-TGA) Truncus arteriosus (Persistent) Tricuspid atresia Interrupted aortic arch Pulmonary atresia (PA) Pulmonary stenosis (critical) Eisenmenger syndrome(Reversal of Shunt due to Pulmonary Hypertension) . Patent ductus arteriosus may cause cyanosis in late stage.

Aortic Stenosis

Abdullatif Al-Rashed

Pulmonary stenosis presentation

Nizam Uddin

Total anomalous pulmonary venous connections seminar ppt.

Pawan Ola

Tricuspid atresia

radhikauppal8

Patent ductus arteriosus

Jerin Thunduparambil

tertalogy of fallot

Patel Dharmendra

Transposition of the great arteries

jagan _jaggi

Atresia tricuspide

IrIs Montaño

Single Ventricle PhysiologyDang Thanh Tuan

What's hot

Tricuspid atresia

Pulmonary stenosis

Atrial Septal Defect

Aortic stenosis

Atrial septal defect

Truncusjensensam

ventricular septal defect

Coarctation of aorta

Tetralogy of fallot

Pulmonary stenosis

Coarctation of aorta.

Dr Inayat Ullah

Ventricular septal defect

Ramachandra Barik

Cyanotic heart disease

Ramachandra Barik

Aortic Stenosis

Abdullatif Al-Rashed

Pulmonary stenosis presentation

Nizam Uddin

Total anomalous pulmonary venous connections seminar ppt.

Pawan Ola

Tricuspid atresia

radhikauppal8

Patent ductus arteriosus

Jerin Thunduparambil

tertalogy of fallot

Patel Dharmendra

Transposition of the great arteries

jagan _jaggi

What's hot (20)

Tricuspid atresia

Pulmonary stenosis

Atrial Septal Defect

Aortic stenosis

Atrial septal defect

Truncus

ventricular septal defect

Coarctation of aorta

Tetralogy of fallot

Pulmonary stenosis

Coarctation of aorta.

Ventricular septal defect

Cyanotic heart disease

Aortic Stenosis

Pulmonary stenosis presentation

Total anomalous pulmonary venous connections seminar ppt.

Tricuspid atresia

Patent ductus arteriosus

tertalogy of fallot

Transposition of the great arteries

Viewers also liked

Atresia tricuspide

IrIs Montaño

Single Ventricle PhysiologyDang Thanh Tuan

Double outlet right ventricle

Ramachandra Barik

Atresia tricuspideaPame Sacco

transposition of great arteriesGopi Krishna Rayidi

Atresia Tricuspidea Expopiratadelcielo@hotmail.com challenger

Cyanotic Heart DiseasesThe Medical Post

Exploring Congenital Heart Defects: Tricsupid Atresiaguest5da87d

Novel fenestration designs for controlled venous flow shunting in failing Fo...

Dorv

Dorv thab

Presentation dorv

Circulatory system

Truncus arteriosus Dr Shiva CTVS JIPMERShivashankar Sadasivam

T a p v cjensensam

Total anomalous pulmonary venous connection

Ramachandra Barik

Cyanotic heart diseaseBalasingam Balagobi

CHD

kyleeburt

Single ventricle presentation for pediatrician

Laxmi Ghimire

Viewers also liked (19)

Atresia tricuspide

Single Ventricle Physiology

Double outlet right ventricle

Atresia tricuspidea

transposition of great arteries

Atresia Tricuspidea Expo

Cyanotic Heart Diseases

Exploring Congenital Heart Defects: Tricsupid Atresia

Novel fenestration designs for controlled venous flow shunting in failing Fo...

Dorv

Dorv thab

Presentation dorv

Circulatory system

Truncus arteriosus Dr Shiva CTVS JIPMER

T a p v c

Total anomalous pulmonary venous connection

Cyanotic heart disease

CHD

Single ventricle presentation for pediatrician

Similar to Tricuspid atresia

Heart.pptx

mariaidrees3

1. Heart.pptx

mariaidrees3

Congenital heart diseases

Arifa T N

C.V.S.ppt

MpOnline7

Common heart conditions in children copy.pptx

RamiHaris

Congenital heart disease

αямαи мαℓιк

congenitalheartdisease-170425182745 (1).pdf

jiregnaetichadako

valve disease and repair and replacement.docx

LolyAli5

• Introduction • Heart valve disease • Classification of heart valve disease • Types of heart valve disease • Etiology • Symptoms • Diagnosis • Treatment • Medication • Surgeries and procedure • Valve repaired • Valve replacement • Valvulopasty • Annuloplasty • Percutaneous or balloon Valvulopasty/valvotomy • Percutaneous mitral valve repair • Commissurotomy • Trans catheter aortic valve implantation or replacement • Open heart surgery • Minimally invasive valve surgery • Port access valve surgery • Robot-assisted surgery • Preparation • Procedure • Complication • Management • Nursing management • Nurse care plan • Follow up • Rehabilitation • Life style reference

Congenital_Heart_Disaese.pptx

ssuser35e86c1

Chd

Eric General

Congenital heart disease, by dr Shaymaa Fayad, El Nasr Hospital Port said

mohamed osama hussein

ACYANOTIC HEART DISEASE

Sachin Gadade

Child with cardiovascular disorder

HI HI

7.congenital heart dss

Whiteraven68

Acyanotic congenital heart defects

Eric General

Unit 9; Peadiatric Cardiology, Educational Platform.pptx

AbdullahAbdullah768178

HEART VALVULAR DISORDERS.pptx

SUDHAGAUTAM6

cyanotic heart disease.pptx

supriya sharma

Congenital heart failures in children

Eneutron

Acyanotic congenital heart disease

Abdul Kareem

Similar to Tricuspid atresia (20)

Heart.pptx

1. Heart.pptx

Congenital heart diseases

C.V.S.ppt

Common heart conditions in children copy.pptx

Congenital heart disease

congenitalheartdisease-170425182745 (1).pdf

valve disease and repair and replacement.docx

Congenital_Heart_Disaese.pptx

Chd

Congenital heart disease, by dr Shaymaa Fayad, El Nasr Hospital Port said

ACYANOTIC HEART DISEASE

Child with cardiovascular disorder

7.congenital heart dss

Acyanotic congenital heart defects

Unit 9; Peadiatric Cardiology, Educational Platform.pptx

HEART VALVULAR DISORDERS.pptx

cyanotic heart disease.pptx

Congenital heart failures in children

Acyanotic congenital heart disease

Recently uploaded

263778731218 Abortion Clinic /Pills In Harare ,

sisternakatoto

263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/

Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx

Dr. Rabia Inam Gandapore

Ophthalmology Clinical Tests for OSCE exam

KafrELShiekh University

Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey

greendigital

Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye. Follow us on: Pinterest Introduction Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing . Early Life and Career Childhood and Athletic Beginnings Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle. Transition to Acting Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness. Fitness Regimen Workout Routine Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show. Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles. Importance of Flexibility and Mobility In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit

Prix Galien International 2024 Forum Program

Levi Shapiro

June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels: - ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING - WOMEN’S HEALTH: FERTILITY PRESERVATION - WHAT’S NEW IN THE TREATMENT OF INFECTIOUS, ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES? - ARTIFICIAL INTELLIGENCE AND ETHICS - GENE THERAPY - BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE - ETHICAL CHALLENGES IN LIFE SCIENCES - Prix Galien International Awards Ceremony

Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya

Dr KHALID B.M

24 Upakrama.pptx class ppt useful in all

DrSathishMS1

New Drug Discovery and Development .....

NEHA GUPTA

The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.

ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf

Anujkumaranit

How STIs Influence the Development of Pelvic Inflammatory Disease.pptx

FFragrant

Ocular injury ppt Upendra pal optometrist upums saifai etawah

pal078100

ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS

Dr. Vinay Pareek

Triangles of Neck and Clinical Correlation by Dr. RIG.pptx

Dr. Rabia Inam Gandapore

Couples presenting to the infertility clinic- Do they really have infertility...

Sujoy Dasgupta

Non-respiratory Functions of the Lungs.pdf

MedicoseAcademics

These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract. Learning objectives: 1. Enlist the non-respiratory functions of the respiratory tract 2. Briefly explain how these functions are carried out 3. Discuss the significance of dead space 4. Differentiate between minute ventilation and alveolar ventilation 5. Describe the cough and sneeze reflexes Study Resources: 1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition 2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition 3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition 4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874

New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...

i3 Health

i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource. This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and Associate Division Director for Ambulatory Operations The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma. STATEMENT OF NEED Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL. Target Audience Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL). Learning Objectives 1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL 2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults 3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection

heat stroke and heat exhaustion in children

SumeraAhmad5

micro teaching on communication m.sc nursing.pdf

Anurag Sharma

POST OPERATIVE OLIGURIA and its management

touseefaziz1

Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...

Oleg Kshivets

RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0). CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.

Recently uploaded (20)

263778731218 Abortion Clinic /Pills In Harare ,

Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx

Ophthalmology Clinical Tests for OSCE exam

Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey

Prix Galien International 2024 Forum Program

Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya

24 Upakrama.pptx class ppt useful in all

New Drug Discovery and Development .....

ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf

How STIs Influence the Development of Pelvic Inflammatory Disease.pptx

Ocular injury ppt Upendra pal optometrist upums saifai etawah

ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS

Triangles of Neck and Clinical Correlation by Dr. RIG.pptx

Couples presenting to the infertility clinic- Do they really have infertility...

Non-respiratory Functions of the Lungs.pdf

New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...

heat stroke and heat exhaustion in children

micro teaching on communication m.sc nursing.pdf

POST OPERATIVE OLIGURIA and its management

Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...